All-trans-retinoic acid release from core-shell type nanoparticles of poly (ε-caprolactone)/poly (ethylene glycol) diblock copolymer

被引:56
作者
Jeong, YI
Kang, MK
Sun, HS
Kang, SS
Kim, HW
Moon, KS
Lee, KJ
Kim, SH
Jung, S [1 ]
机构
[1] Chonnam Natl Univ, Sch Med, Brian Tumor Res Lab, Kwangju 501746, South Korea
[2] Chonnam Natl Univ Hosp & Med Sch, Dept Neurosurg, Kwangju 501746, South Korea
[3] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Kwangju 501746, South Korea
关键词
all-trans-retinoic acid; core-shell type nanoparticles; biodegradable; sustained release;
D O I
10.1016/j.ijpharm.2003.12.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poly(E-caprolactone)/poly(ethylene glycol) (abbreviated as CE) diblock copolymers were synthesized to make core-shell type nanoparticles for all-trans-retinoic acid (atRA). Fluorescence spectroscopy showed that critical association concentration (CAC) value decreased at higher MW of CE diblock copolymer. Drug loading characteristics were studied under various experimental conditions. Drug contents and loading efficiency increased as the MW of poly(E-caprolactone) (PCL) block of CE and initial drug feeding amount increased. Solvent used and preparation method also affected drug contents and loading efficiency. According to H-1 NMR using CDCl3 and D2O, specific peaks of the PCL block and drug appearing in CDCl3, disappeared at D2O, suggesting hydrophobic core with hydrophilic shell formed in water. atRA release was faster at smaller MW of copolymer and lower drug contents. Nanoparticles prepared in DMF showed faster release rate compared with those prepared in THF or acetone. Cytotoxicity of atRA against U87MG, U251MG and U343MG cell lines were increased by nanoencapsulation while empty nanoparticles of CE diblock copolymer were not significantly affected. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:95 / 107
页数:13
相关论文
共 27 条
  • [1] ACHKAR CC, 1994, DRUG METAB DISPOS, V22, P451
  • [2] ALLEY MC, 1988, CANCER RES, V48, P589
  • [3] Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines
    Bouterfa, H
    Picht, T
    Kess, D
    Herbold, C
    Noll, E
    Black, PM
    Roosen, K
    Tonn, JC
    [J]. NEUROSURGERY, 2000, 46 (02) : 419 - 430
  • [4] POLYETHER POLYESTER BLOCK COPOLYMERS BY NON-CATALYZED POLYMERIZATION OF EPSILON-CAPROLACTONE WITH POLY(ETHYLENE GLYCOL)
    CERRAI, P
    TRICOLI, M
    ANDRUZZI, F
    PACI, M
    PACI, M
    [J]. POLYMER, 1989, 30 (02) : 338 - 343
  • [5] All-trans retinoic acid in relapsing malignant gliomas: Clinical and radiological stabilization associated with the appearance of intratumoral calcifications
    Defer, GL
    AdleBiassette, H
    Ricolfi, F
    Martin, L
    Authier, FJ
    Chomienne, C
    Degos, L
    Degos, JD
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1997, 34 (02) : 169 - 177
  • [6] Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid
    Estey, E
    Thall, PF
    Mehta, K
    Rosenblum, M
    Brewer, T
    Simmons, V
    Cabanillas, F
    Kurzrock, R
    LopezBerestein, G
    [J]. BLOOD, 1996, 87 (09) : 3650 - 3654
  • [7] Giannini F, 1997, INT J CANCER, V70, P194
  • [8] BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES
    GREF, R
    MINAMITAKE, Y
    PERACCHIA, MT
    TRUBETSKOY, V
    TORCHILIN, V
    LANGER, R
    [J]. SCIENCE, 1994, 263 (5153) : 1600 - 1603
  • [9] USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    HUANG, ME
    YE, YC
    CHEN, SR
    CHAI, JR
    LU, JX
    ZHOA, L
    GU, LJ
    WANG, ZY
    [J]. BLOOD, 1988, 72 (02) : 567 - 572
  • [10] Jeong YI, 2002, B KOREAN CHEM SOC, V23, P1579